Where GHRP-2 offers potency at the cost of a broader hormonal footprint, ipamorelin trades a slice of the ghrelin-like breadth for a cleaner, GH-focused signal
Semaglutide is approved for chronic, long-term use with a favorable tolerability profile when used as monotherapy
Research indicates that stopping GLP-1 weight reduction medications, such as Mounjaro or Zepbound, could lead to weight gain, with some individuals regaining up to 12-15% of their initial weight
This is a critical gap in the research
By then, even surgical interventions may not fully restore whats been lost, as the fundamental changes to skin quality and structure can potentially become permanent
Consult with a healthcare professional before use if you are pregnant, nursing, taking medication, or have a medical condition